明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002932 明德生物

已收盘 12-20 15:00:00

{"stockData":{"symbol":"002932","market":"SZ","secType":"STK","nameCN":"明德生物","latestPrice":19.03,"timestamp":1734678222000,"preClose":18.78,"halted":0,"volume":1227377,"delay":0,"floatShares":156000000,"shares":233000000,"eps":0.0455,"marketStatus":"已收盘","marketStatusCode":5,"change":0.25,"latestTime":"12-20 15:00:00","open":18.8,"high":19.12,"low":18.7,"amount":23304900,"amplitude":0.0224,"askPrice":19.03,"askSize":6,"bidPrice":19,"bidSize":59,"shortable":0,"etf":0,"ttmEps":0.0455,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":18.78,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":20.66,"lowLimit":16.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":232520957,"pbRate":0.74,"roa":"--","roe":"1.35%","epsLYR":0.33,"committee":-0.025729,"marketValue":4425000000,"floatMarketCap":2970000000,"peRate":418.241767,"changeRate":0.0133,"turnoverRate":0.0079,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-12-23。"},"requestUrl":"/m/hq/s/002932","defaultTab":"news","newsList":[{"id":"2491349469","title":"明德生物(002932)12月10日股东户数2.81万户，较上期减少4.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491349469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491349469?lang=zh_cn&edition=full","pubTime":"2024-12-13 17:03","pubTimestamp":1734080627,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物披露，截至2024年12月10日公司股东户数为2.81万户，较11月29日减少1230.0户，减幅为4.19%。在医疗器械行业个股中，明德生物股东户数高于行业平均水平，截至12月10日，医疗器械行业平均股东户数为2.04万户。从股价来看，2024年11月29日至2024年12月10日，明德生物区间涨幅为0.05%，在此期间股东户数减少1230.0户，减幅为4.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300029596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2488625247","title":"明德生物最新公告：回购公司股份比例达到5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488625247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488625247?lang=zh_cn&edition=full","pubTime":"2024-12-02 16:50","pubTimestamp":1733129414,"startTime":"0","endTime":"0","summary":"明德生物公告，截至2024年11月29日，公司累计通过回购专用证券账户以集中竞价方式回购公司股份11,745,043股，占公司总股本的5.05%；回购股份最高成交价为20.98元/股，最低成交价为15.33元/股，总成交金额为人民币2.24亿元（不含交易税费）。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120200021099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2488362301","title":"明德生物(002932.SZ)已累计回购5.05%股份 耗资约2.24亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488362301","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488362301?lang=zh_cn&edition=full","pubTime":"2024-12-02 16:35","pubTimestamp":1733128527,"startTime":"0","endTime":"0","summary":"智通财经APP讯，明德生物(002932.SZ)发布公告，截至2024年11月29日，公司累计通过回购专用证券账户以集中竞价方式回购公司股份1174.5万股，占公司总股本的5.05%;回购股份最高成交价为20.98元/股，最低成交价为15.33元/股，总成交金额为人民币2.24亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1218946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2487467653","title":"明德生物新注册《急诊急救大平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2487467653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487467653?lang=zh_cn&edition=full","pubTime":"2024-11-29 01:18","pubTimestamp":1732814289,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物（002932）新注册了《急诊急救大平台V1.0》项目的软件著作权。今年以来明德生物新注册软件著作权11个，较去年同期增加了22.22%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了5522.46万元，同比减23.23%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900000380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2486333276","title":"明德生物（002932）11月27日主力资金净买入1003.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486333276","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486333276?lang=zh_cn&edition=full","pubTime":"2024-11-28 09:21","pubTimestamp":1732756901,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月27日收盘，明德生物报收于19.85元，下跌0.95%，换手率4.91%，成交量7.67万手，成交额1.51亿元。近5日资金流向一览见下表：明德生物融资融券信息显示，融资方面，当日融资买入4496.88万元，融资偿还3971.37万元，融资净买入525.51万元。明德生物主营业务：主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800007499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2486475868","title":"明德生物（002932）11月26日主力资金净买入2723.50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486475868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486475868?lang=zh_cn&edition=full","pubTime":"2024-11-27 09:14","pubTimestamp":1732670071,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月26日收盘，明德生物报收于20.04元，上涨2.87%，换手率3.88%，成交量6.05万手，成交额1.2亿元。近5日资金流向一览见下表：明德生物融资融券信息显示，融资方面，当日融资买入3276.94万元，融资偿还1591.76万元，融资净买入1685.18万元。明德生物主营业务：主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700008451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2486888026","title":"明德生物(002932)11月20日股东户数3.01万户，较上期增加3.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486888026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486888026?lang=zh_cn&edition=full","pubTime":"2024-11-26 17:03","pubTimestamp":1732611838,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物披露，截至2024年11月20日公司股东户数为3.01万户，较11月8日增加1051.0户，增幅为3.62%。在医疗器械行业个股中，明德生物股东户数高于行业平均水平，截至11月20日，医疗器械行业平均股东户数为2.05万户。从股价来看，2024年11月8日至2024年11月20日，明德生物区间涨幅为6.71%，在此期间股东户数增加1051.0户，增幅为3.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600028605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2485471771","title":"明德生物（002932）11月21日主力资金净卖出451.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485471771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485471771?lang=zh_cn&edition=full","pubTime":"2024-11-22 09:20","pubTimestamp":1732238416,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月21日收盘，明德生物报收于19.86元，下跌2.5%，换手率4.84%，成交量7.55万手，成交额1.51亿元。近5日资金流向一览见下表：明德生物融资融券信息显示，融资方面，当日融资买入2090.25万元，融资偿还3684.15万元，融资净偿还1593.9万元。明德生物主营业务：主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200008303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2484599291","title":"明德生物(002932)11月8日股东户数2.91万户，较上期减少3.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484599291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484599291?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:02","pubTimestamp":1732006970,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物披露，截至2024年11月8日公司股东户数为2.91万户，较10月18日减少1187.0户，减幅为3.92%。户均持股数量由上期的7688.0股增加至8002.0股，户均持股市值为15.28万元。在医疗器械行业个股中，明德生物股东户数高于行业平均水平，截至11月8日，医疗器械行业平均股东户数为2.05万户。根据统计，明德生物2024年10月18日至2024年11月8日，主力资金净流出1910.73万元，游资资金净流出917.46万元，散户资金净流入2828.19万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900027233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2480731099","title":"明德生物（002932）2024年三季报简析：净利润减44.3%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2480731099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480731099?lang=zh_cn&edition=full","pubTime":"2024-11-01 06:47","pubTimestamp":1730414854,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期明德生物发布2024年三季报。截至本报告期末，公司营业总收入2.26亿元，同比下降63.95%，归母净利润8093.84万元，同比下降44.3%。按单季度数据看，第三季度营业总收入7134.75万元，同比下降19.26%，第三季度归母净利润1577.58万元，同比下降51.8%。本报告期明德生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达168.22%。去年的净利率为9.23%，算上全部成本后，公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100007643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932"],"gpt_icon":0},{"id":"2479772623","title":"明德生物(002932)10月18日股东户数3.02万户，较上期减少2.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479772623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479772623?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:22","pubTimestamp":1730366578,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物披露，截至2024年10月18日公司股东户数为3.02万户，较10月10日减少928.0户，减幅为2.98%。在医疗器械行业个股中，明德生物股东户数高于行业平均水平，截至10月18日，医疗器械行业平均股东户数为2.03万户。从股价来看，2024年10月10日至2024年10月18日，明德生物区间跌幅为0.5%，在此期间股东户数减少928.0户，减幅为2.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100034851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2479758242","title":"图解明德生物三季报：第三季度单季净利润同比减51.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479758242","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479758242?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:58","pubTimestamp":1730311137,"startTime":"0","endTime":"0","summary":"证券之星消息，明德生物2024年三季报显示，公司主营收入2.26亿元，同比下降63.95%；归母净利润8093.84万元，同比下降44.3%；扣非净利润-3907.66万元，同比下降185.76%；其中2024年第三季度，公司单季度主营收入7134.75万元，同比下降19.26%；单季度归母净利润1577.58万元，同比下降51.8%；单季度扣非净利润-1025.39万元，同比下降197.08%；负债率10.54%，投资收益7845.6万元，财务费用-674.09万元，毛利率51.79%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100003057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932"],"gpt_icon":0},{"id":"2479206155","title":"明德生物(002932.SZ)发布前三季度业绩，净利润8093.84万元，同比下降44.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479206155","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479206155?lang=zh_cn&edition=full","pubTime":"2024-10-30 19:57","pubTimestamp":1730289436,"startTime":"0","endTime":"0","summary":"智通财经APP讯，明德生物(002932.SZ)发布2024年三季度报告，前三季度，公司实现营业收入2.26亿元，同比下降63.95%。归属于上市公司股东的净利润8093.84万元，同比下降44.30%。归属于上市公司股东的扣除非经常性损益净亏损3907.66万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204029.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932"],"gpt_icon":0},{"id":"2476113525","title":"明德生物(002932)10月10日股东户数3.12万户，较上期减少2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476113525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476113525?lang=zh_cn&edition=full","pubTime":"2024-10-17 17:02","pubTimestamp":1729155746,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物披露，截至2024年10月10日公司股东户数为3.12万户，较9月30日减少639.0户，减幅为2.01%。在医疗器械行业个股中，明德生物股东户数高于行业平均水平，截至10月10日，医疗器械行业平均股东户数为2.0万户。从股价来看，2024年9月30日至2024年10月10日，明德生物区间跌幅为7.01%，在此期间股东户数减少639.0户，减幅为2.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101700025205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2474832719","title":"明德生物(002932.SZ)中期权益分派：每10股派0.3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474832719","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474832719?lang=zh_cn&edition=full","pubTime":"2024-10-10 19:19","pubTimestamp":1728559150,"startTime":"0","endTime":"0","summary":"智通财经APP讯，明德生物(002932.SZ)发布公告，公司2024年中期权益分派方案为：以现有总股本剔除已回购股份后的股本为基数，向全体股东每10股派0.3元人民币现金(含税)，本次权益分派的股权登记日为：2024年10月16日，除权除息日为：2024年10月17日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1192548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2470687788","title":"明德生物(002932.SZ)累计回购4.03%股份 耗资1.79亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470687788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470687788?lang=zh_cn&edition=full","pubTime":"2024-09-26 17:38","pubTimestamp":1727343525,"startTime":"0","endTime":"0","summary":"智通财经APP讯，明德生物(002932.SZ)公告，公司截至2024年9月25日以集中竞价方式回购公司股份936.99万股，占公司总股本的4.03%;总成交金额为人民币1.79亿元(不含交易税费)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1187603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2470214785","title":"【企业动态】明德生物新增1件法院诉讼，案由为追索劳动报酬纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2470214785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470214785?lang=zh_cn&edition=full","pubTime":"2024-09-26 06:18","pubTimestamp":1727302692,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，9月19日明德生物（002932）新增1件法院诉讼如下：案号：（2024）鄂0192民初12030号法院：武汉东湖新技术开发区人民法院案由：追索劳动报酬纠纷原告：张某某被告：武汉明德生物科技股份有限公司案件类型：民事立案日期：2024年9月19日数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092600003583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2468659115","title":"明德生物（002932）9月19日主力资金净买入17.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468659115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468659115?lang=zh_cn&edition=full","pubTime":"2024-09-20 09:24","pubTimestamp":1726795445,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月19日收盘，明德生物报收于15.66元，上涨0.19%，换手率0.83%，成交量1.3万手，成交额2034.47万元。近5日资金流向一览见下表：明德生物融资融券信息显示，融资方面，当日融资买入110.65万元，融资偿还357.56万元，融资净偿还246.91万元。明德生物主营业务：主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092000005868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2467723685","title":"明德生物：截至2024年9月10日，公司股东总户数为31808","url":"https://stock-news.laohu8.com/highlight/detail?id=2467723685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467723685?lang=zh_cn&edition=full","pubTime":"2024-09-13 19:00","pubTimestamp":1726225237,"startTime":"0","endTime":"0","summary":"证券之星消息，明德生物(002932)09月13日在投资者关系平台上答复投资者关心的问题。投资者：董秘您好，请告诉一下目前，公司的最新股东人数。明德生物董秘：尊敬的投资者您好，截至2024年9月10日，公司股东总户数为31808。感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091300035346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2464378270","title":"明德生物：公司净资产减少主要系公司开展股票回购及分红所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2464378270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464378270?lang=zh_cn&edition=full","pubTime":"2024-09-04 19:00","pubTimestamp":1725447657,"startTime":"0","endTime":"0","summary":"明德生物董秘：尊敬的投资者您好，公司重视投资者回报，后续将按照相关规定及公司回购股份方案，根据市场情况在回购期限内继续实施回购，并在回购期间严格遵照相关法律、法规和规范性文件的要求及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090400032205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-07-10","address":"湖北省武汉市江夏区东湖新技术开发区高新二路388号武汉光谷国际生物医药企业加速器3.1期25栋1层(3)厂房三号","stockEarnings":[{"period":"1week","weight":-0.0365},{"period":"1month","weight":-0.0658},{"period":"3month","weight":0.2298},{"period":"6month","weight":0.0661},{"period":"1year","weight":-0.1696},{"period":"ytd","weight":-0.1649}],"companyName":"武汉明德生物科技股份有限公司","boardCode":"AI0027","perCapita":"5546股","boardName":"医药制造业","registeredCapital":"23252万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":"　　武汉明德生物科技股份有限公司主要从事体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司主要产品和服务覆盖三大领域：体外诊断试剂和仪器、急危重症信息化解决方案、第三方医学检验服务。2022年12月，在中国心血管健康大会上，采用公司信息化解决方案的湖北省英山县人民医院荣获智慧胸痛中心建设最佳解决方案金奖，成为全国唯一一家荣获智慧胸痛中心建设最佳解决方案金奖的县级医院。","serverTime":1734726733996,"listedPrice":20.45,"stockholders":"28141人(较上一季度减少4.19%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供明德生物(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"明德生物,002932,明德生物股票,明德生物股票老虎,明德生物股票老虎国际,明德生物行情,明德生物股票行情,明德生物股价,明德生物股市,明德生物股票价格,明德生物股票交易,明德生物股票购买,明德生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供明德生物(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}